Queen Mary University Clinical Research Fellow 2026: Applications Now Open for Barts Cancer Institute, UK

The Queen Mary University of London Clinical Research Fellow programme is now open for applications, offering medical professionals the opportunity to undertake high-impact research within the Barts Cancer Institute. With a deadline of 19 February 2026, this competitive role provides a unique pathway for clinicians to secure a PhD in Haemato-Oncology while delivering clinical duties at The London Clinic.

The fellowship is designed as a fixed-term appointment for 4 years, enabling fellows to combine academic research with clinical practice. For 2026, the Institute is offering two full-time posts based at the Charterhouse Square Campus in London. Successful applicants will receive a competitive salary on the clinical academic pay scale, ranging from £65,048 to £73,992 per annum (inclusive of London Allowance). The roles feature expected start dates in September 2026 and April 2027.

Clinical Research Fellowship Objectives

The fellowship aims to bridge the gap between clinical practice and innovative research to transform the lives of cancer patients. Its core objectives include:

• Undertaking a research project resulting in a PhD within the Centre for Haemato-Oncology

• Delivering clinical duties on a rota basis alongside other Clinical Research Fellows

• Contributing to ground-breaking basic research combined with clinical expertise

• Supporting the Barts Cancer Institute’s status as a Cancer Research UK Centre of Excellence

• Developing future cancer researchers through extensive postgraduate training

About the Host Institute

The 2026 Fellowship is hosted by the Barts Cancer Institute (BCI), a Cancer Research UK Centre of Excellence internationally renowned for transforming patient care.

As part of the Faculty of Medicine and Dentistry, BCI combines laboratory research with the expertise of clinicians from the Centre for Experimental Cancer Medicine and the Barts NHS Trust. The institute acts as a partner in the CRUK City of London Major Centre—a Centre of Excellence in Biotherapeutics—alongside UCL, King’s College, and the Francis Crick Institute.

Queen Mary University emphasizes social justice and academic excellence, believing that diversity of thought leads to truly original innovation.

Eligibility Criteria

Applicants must meet the following eligibility requirements:

• Haematology SpR in a training post or have completed CCT

• Possession of MRCP or equivalent qualification

• Working towards or have obtained FRCPath (Haem)

• Intention to undertake an out-of-program research project leading to a PhD award

• Full eligibility conditions are outlined in the official job description.

Key Dates

• Job Posted: 27 January 2026

• Application Deadline: 19 February 2026

• Expected Start Dates: September 2026 and April 2027

How to Apply

Applications must be submitted through the Queen Mary University online recruitment portal (Reference: 8668) before the closing date. The university is committed to diverse and inclusive appointments, offering reasonable adjustments for candidates with disabilities at every stage of the recruitment process.

Applicants will benefit from competitive salaries, a generous pension scheme, 30 days’ annual leave, and access to comprehensive professional development opportunities.

For accessing the application, click here.

To know more about such opportunities, click here.